Showing results (531-540 of 1,104) with videos related to

Sort By:
Pageof 111
Molecular Cancer Therapeutics|February 28, 2018
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 InsertionsNicolas Floc'h, Matthew J Martin, Jonathan W Riess, et al.
West African Journal of Medicine|November 16, 2023
CASE FATALITY RATE OF CHILDHOOD TUBERCULOSIS: EXPERIENCE FROM FEDERAL TEACHING HOSPITAL GOMBE: A TWO DECADE REVIEWW E Isaac, I Jalo, G Yohanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid TumorsNeelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
Journal of Inherited Metabolic Disease|February 14, 2021
Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDGHind Alsharhan, Bobby G Ng, Earnest James Paul Daniel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal CancerJonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
West African Journal of Medicine|November 16, 2023
IN-PATIENT PNEUMONIA BURDEN AND CASE FATALITY RATES IN CHILDREN OVER TWO DECADES IN FEDERAL TEACHING HOSPITAL, GOMBE (FTHG)W E Isaac, I Jalo, G Yohanna, et al.
The Journal of Clinical Investigation|October 4, 2019
Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapyCatherine E Willoughby, Yanyan Jiang, Huw D Thomas, et al.
Clinical and Translational Science|August 29, 2024
Lexicon for blood-based early detection and screening: BLOODPAC consensus documentChristina A Clarke, Breeana L Mitchell, Girish Putcha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer DetectionChristina A Clarke, Breeana L Mitchell, Emma Alme, et al.
Pageof 111